Healthcare Cost of Smoking Induced Cardiovascular Disease in Tanzania
- PMID: 27152318
- PMCID: PMC4853883
- DOI: 10.17265/2328-7136/2015.03.003
Healthcare Cost of Smoking Induced Cardiovascular Disease in Tanzania
Abstract
The study presented here estimates the total health care cost attributable to smoking induced cardiovascular disease in Tanzania. The study based on a survey conducted at a referral university hospital in Dar es Salaam in 2014. Assuming a 2% prevalence rate of cardiovascular disease and a population of 47.2 million, it was estimated that there are 943,800 cardiovascular patients in Tanzania. The proportion of ever smokers among the surveyed patients was found to be 25 percent yielding 240,400 patients who suffer from smoking induced cardiovascular diseases. Per capita annual expenditure per patient is estimated to be 566.6 US dollars and total annual expenditure for the country was estimated to be 136.1 million US dollars. On a per capita basis more direct and indirect cost is incurred on males compared to females; more is spent on the elderly (40 or more years) compared to the youth (less than 20 years). When compared with the mean annual household income of the surveyed population, the smoking induced per capita expenditure constitutes 35% of household income.
Keywords: Healthcare; Tanzania; cardiovascular; cost; smoking.
Conflict of interest statement
There is no conflict of interest
Similar articles
-
Impact of Smoking on Food Expenditure among Tanzanian Households.Afr Stat J. 2015 Sep;18:69-78. Afr Stat J. 2015. PMID: 28008385 Free PMC article.
-
Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model.Int J Drug Policy. 2021 Feb;88:102634. doi: 10.1016/j.drugpo.2019.102634. Epub 2019 Dec 24. Int J Drug Policy. 2021. PMID: 31882272
-
Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania.BMJ. 1993 Jun 12;306(6892):1570-2. doi: 10.1136/bmj.306.6892.1570. BMJ. 1993. PMID: 8329915 Free PMC article.
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
Cited by
-
The Economic Cost of Smoking in South Africa, 2016.Nicotine Tob Res. 2021 Jan 22;23(2):286-293. doi: 10.1093/ntr/ntaa162. Nicotine Tob Res. 2021. PMID: 32832993 Free PMC article.
-
The Economic Costs of Tobacco Related Illnesses in Kenya.Tob Use Insights. 2024 Aug 12;17:1179173X241272385. doi: 10.1177/1179173X241272385. eCollection 2024. Tob Use Insights. 2024. PMID: 39139515 Free PMC article.
-
Cardiovascular disease in Africa: epidemiological profile and challenges.Nat Rev Cardiol. 2017 May;14(5):273-293. doi: 10.1038/nrcardio.2017.19. Epub 2017 Feb 23. Nat Rev Cardiol. 2017. PMID: 28230175 Review.
References
-
- United Republic of Tanzania. Statistical Abstracts 2013 2014
-
- WHO. Report on the global tobacco epidemic, 2013. 2013 accessed December 15, 2014. www.who.int/iris/bitstream/10665/85380/1/9789241505871_eng.pdf.
-
- Mundi Index. 2012 Accessed December 15, 2014. http://www.indexmundi.com/facts/indicators/SH.PRV.SMOK.FE/rankings.
-
- Kalage R, Blomstedt R, Preet K, Hoffman MB, Kinsman J. INTREC Tanzania Country Report 2012
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources